The year 2021 wrapped up on an all-time high note for the startup and VC ecosystem. At Enzia, it was no different. In this quarter, in alignment with our thesis-based approach, we announced our investment in ZenOnco.io, one of India’s few startups in the field of integrative oncology. By investing in ZenOnco.io, we take an important step towards realising our mission of driving affordability and accessibility of holistic healthcare. More about the company and our investment thesis is in the ‘Our Portfolio’ section.
This quarter has been one of celebrating our portfolio’s milestones and wins. From customer successes to innovative outreach initiatives to raising more funds, our portfolio companies have put up some impressive performances this quarter. Meanwhile, we have been raising our fund and bringing on board some truly visionary people as investors to support us on our journey.
There’s a lot to look forward to in the current quarter. We will also be closing our first round of funds soon, which we will be announcing shortly .We will be launching a video series in which we discuss the importance of an outcomes-focused approach with our portfolio companies. This approach is at the core of Enzia’s principles, and we both seek and nurture it in our portfolio. You can read more about its essence in ‘Enzia Insights’.
We’re actively interviewing for the role of Investment Analyst in our team. We request you to please spread the word and connect us with people in your network. Details of the job profile can be found here.
We hope you have begun 2022 on a good note, and we look forward to many fruitful interactions with you this year!
ZenOnco.io is a comprehensive integrative oncology platform. Built along the verticals of community, comprehensive treatment support, and relevant products and services, it aims to be a one-stop platform which cancer patients trust during their treatment journey.
Enzia Ventures led ZenOnco.io’s seed round of USD 1.4mn with Better Capital, Apollo Hospitals, Titan Capital and others.
Click here to read why we decided to invest in ZenOnco.io.
Our investment was widely covered by the media. A glimpse:
The Week: Oncology Innovator ZenOnco.io Raises USD 1.4mn From Enzia Ventures Better Capital Others - The Week
It has been a year of superlatives for leap.club. Membership expanded by 6x while ARR grew 15x. The leap.club team expanded and is now strong at 30+. At the beginning of 2021, leap.club members hailed from three countries; now, leap.club has members spread across 12, and continues to add 500+ members every month. In 2022, leap.club aspires to rapidly expand both its team and memberships, as well as further infuse product DNA in everything it builds.
Community engagement has been at the heart of CuriousJr right since its inception. Continuing this spirit, CuriousJr held an All India Coding Championship in November 2021. More than 25,000 students in the age group 8-18 years and from at least six states participated in the championship. Many of these students were from Tier-II, Tier-III cities. Through the championship, CuriousJr expanded its reach exponentially to include schools from across the country in “the Coders Club”, an initiative CuriousJr started in order to integrate promising schools in its ecosystem.
We were able to facilitate an interview of the founders on Next Big Brand, an e-portal covering promising names in the startup ecosystem. Click here to check it out.
Within seven months of launch, Enzia's angel investment Kafqa crossed 1 lakh student registrations and saw 40x growth. Currently, Kafqa’s online-offline classes for eight styles of music, dance & acting garner traffic from 600+ cities across India and conduct 50,000+ minutes of live learning every day. The growth is bringing significant support and customer success: 25% of the traffic is organic i.e., through word of mouth and content sharing, while satisfaction rates are at an average of 4.6/5. In 2022, Kafqa aspires to grow 12x, into one of India’s largest learning platforms for performing arts.
Among Enzia's angel investments, the iMumz app is now loved by 500,000 women and the company is eyeing to reach 2 Million women in 2022 alone. They have launched new products, doubling the ARPU by October 2021, and monthly revenue has increased 9x since the time of investment.
VCCiRCLE covered our journey, as well as the support and commitments we’ve received from our investors so far. Click here to read the entire story.
Al Jazeera featured us and one of our portfolio founders, Ragini Das, in this piece on Indian women rising in the startup and VC ecosystem. Here's what we said.
Healthcare
Jayshree Kanther Patodi was on the panel of evaluators for the healthtech and medtech domains at the Final Round of the NBEC 2021 held by C-CAMP & BIRAC in December 2021. The NBEC is an annual competition for entrepreneurs across healthtech, medtech, cleantech and agritech domains, to name a few. Enzia has been a proud partner at this event.
I-Ventures, the business incubator at ISB, Hyderabad, invited Jayshree Kanther Patodi at the Venture Capital Conference in December 2021. She participated in a closed-door fireside chat along with fellow investors Vaani Kola (Kalaari Capital), Nandini Mansinghka (Mumbai Angels Network), Varun Laul (Investcorp), Sanjay Nath (Blume Ventures) and Shilpa Kumar (ON India). Watch the discussion here.
Environment
Karuna Jain participated in a closed-door panel discussion titled ‘Industry Forum Roundtable: Engaging Investors in Smart Protein’ at the Smart Protein Summit 2021, the flagship event of The Good Food Institute India.
An outcomes-focused approach is among Enzia’s core principles, but how does it lead to impact and financial returns? Namita Dalmia and Karuna Jain co-author an article connecting the dots. Click to read the full article.
Did you miss our last newsletter? You can access it here. To get on our subscription list, please write to marcomm@enzia.vc. or simply subscribe in the footer below.
Enzia is now on LinkedIn and Twitter! Follow us on the links below to get regular information, updates and insights and more.